Boehringer Ingelheim Chooses CREON·LAB·CONTROL for their Electronic Record Management Solution

26-Sep-2002

Cologne, September 25, 2002 - CREON·LAB·CONTROL, the pioneer in intelligent analytical data management technology, today announced it has received a corporate license order for Q-DIS/PANDA software and services from Boehringer Ingelheim, one of the 20 leading pharmaceutical corporations in the world.

The new product of CREON·LAB·CONTROL, Q-DIS/PANDA, is a platform-independent, 100% web based central storage system, which harvest all kinds of widely dispersed information (electronic records) to generate a powerful knowledge-based corporate archive.

Boehringer Ingelheim has been using CREON·LAB·CONTROL software solutions for seven years. Starting as a development partner for Q-DIS/AQV they have helped to optimize the specification management of analytical testing methods as well as increasing productivity by using the Q-DIS/QM LIMS and Q-DIS/R Analytical R&D Workflow System. With the new product Q-DIS/PANDA, Boehringer Ingelheim is strengthening its commitment to CREON·LAB·CONTROL solutions. Boehringer Ingelheim plans to lever the Q-DIS/PANDA software solution for electronic record management and corporate archiving especially within R&D and production.

"Once again, CREON·LAB·CONTROL has demonstrated our ability to help customers improve their entire product development processes," said Dr. Daniela Weber, Sales Director at CREON·LAB·CONTROL. "By using the breadth of CREON·LAB·CONTROL 's software solutions, Boehringer Ingelheim is able to create innovative products in a collaborative environment and control, store, as well as retrieve the data for later reuse. We are pleased to expand our partnership with Boehringer Ingelheim and to continue to deliver quality products and services to them."

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!